These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8374536)

  • 1. Single-drug oral antibacterial prophylaxis with ofloxacin in BMT recipients.
    Schmeiser T; Kern WV; Hay B; Hertenstein B; Arnold R
    Bone Marrow Transplant; 1993 Jul; 12(1):57-63. PubMed ID: 8374536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection prevention in autologous bone marrow transplantation and the role of protective isolation.
    Dekker AW; Verdonck LF; Rozenberg-Arska M
    Bone Marrow Transplant; 1994 Jul; 14(1):89-93. PubMed ID: 7951125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia].
    Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF.
    Offidani M; Corvatta L; Olivieri A; Rupoli S; Frayfer J; Mele A; Manso E; Montanari M; Centurioni R; Leoni P
    Bone Marrow Transplant; 1999 Nov; 24(10):1079-87. PubMed ID: 10578158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
    Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
    Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation.
    Hori A; Kami M; Kim SW; Chizuka A; Kojima R; Imataki O; Sakiyama M; Hamaki T; Onishi Y; Usubuchi N; Kishi Y; Murashige N; Tajima K; Miyakoshi S; Heike Y; Masuo S; Taniguchi S; Takaue Y
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):65-72. PubMed ID: 14752781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases.
    Krüger W; Rüssmann B; Kröger N; Salomon C; Ekopf N; Elsner HA; Kaulfers PM; Mack D; Fuchs N; Dürken M; Kabisch H; Erttmann R; Zander AR
    Bone Marrow Transplant; 1999 Mar; 23(6):589-97. PubMed ID: 10217190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis and treatment of infection in the bone marrow transplant recipient.
    Winston DJ
    Curr Clin Top Infect Dis; 1993; 13():293-321. PubMed ID: 8397916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
    Hidalgo M; Hornedo J; Lumbreras C; Trigo JM; Colomer R; Perea S; Gómez C; Ruiz A; García-Carbonero R; Cortés-Funes H
    Cancer; 1999 Jan; 85(1):213-9. PubMed ID: 9921995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.
    Parody R; Martino R; Rovira M; Vazquez L; Vázquez MJ; de la Cámara R; Blazquez C; Fernández-Avilés F; Carreras E; Salavert M; Jarque I; Martín C; Martínez F; López J; Torres A; Sierra J; Sanz GF;
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis in blood and marrow transplant recipients.
    Yuen KY; Woo PC
    Hematol Oncol; 2002 Jun; 20(2):51-62. PubMed ID: 12111868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients.
    Mossad SB; Longworth DL; Goormastic M; Serkey JM; Keys TF; Bolwell BJ
    Bone Marrow Transplant; 1996 Aug; 18(2):265-71. PubMed ID: 8864433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients.
    De Pauw BE; Donnelly JP; De Witte T; Nováková IR; Schattenberg A
    Bone Marrow Transplant; 1990 Mar; 5(3):179-82. PubMed ID: 2184908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation.
    Menichetti F; Felicini R; Bucaneve G; Aversa F; Greco M; Pasquarella C; Moretti MV; Del Favero A; Martelli MF
    Bone Marrow Transplant; 1989 Sep; 4(5):489-92. PubMed ID: 2790326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.
    Kern WV; Hay B; Kern P; Marre R; Arnold R
    Antimicrob Agents Chemother; 1994 Mar; 38(3):465-72. PubMed ID: 8203838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications.
    Ferrà C; de Sanjosé S; Lastra CF; Martí F; Mariño EL; Sureda A; Brunet S; Gallardo D; Berlanga JJ; García J; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(12):1075-80. PubMed ID: 9466281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autopsy-identified infections among bone marrow transplant recipients: a clinico-pathologic study of 56 patients. Bone Marrow Transplantation Team.
    Chandrasekar PH; Weinmann A; Shearer C
    Bone Marrow Transplant; 1995 Nov; 16(5):675-81. PubMed ID: 8547865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H
    Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.